Despite the proven antiproliferative and/or anti-inflammatory effect of the drugs, none of the coatings significantly reduced LLL compared to uncoated balloons and thus, based on the results presented here, none of the tested coatings may be considered a substitute for the paclitaxel-based coatings currently in clinical use.
No takes yet. Share an insight, caveat, or question.
Haase et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: